Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST

Vor Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
73.5543.4827.8831.7228.8721.49
Research & Development
74.17298.4693.3194.3264.5547.53
Operating Expenses
147.71341.94121.19126.0493.4269.02
Operating Income
-147.71-341.94-121.19-126.04-93.42-69.02
Interest & Investment Income
15.685.874.278.171.320.12
Other Non Operating Income (Expenses)
1,511-334.36----
EBT Excluding Unusual Items
1,379-670.43-116.91-117.86-92.09-68.9
Merger & Restructuring Charges
-29.71-29.71----
Gain (Loss) on Sale of Assets
4.154.15----
Pretax Income
1,354-695.98-116.91-117.86-92.09-68.9
Net Income
1,354-695.98-116.91-117.86-92.09-68.9
Preferred Dividends & Other Adjustments
-----1.23
Net Income to Common
1,354-695.98-116.91-117.86-92.09-70.13
Net Income Growth
------
Shares Outstanding (Basic)
44103322
Shares Outstanding (Diluted)
44103322
Shares Change
682.04%187.35%2.26%69.88%18.30%15547.86%
EPS (Basic)
30.51-70.50-34.03-35.08-46.57-41.95
EPS (Diluted)
30.51-70.50-34.03-35.08-46.57-41.95
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-119.68-143.65-99.89-101.36-93.61-73.04
Free Cash Flow Per Share
-2.70-14.55-29.07-30.17-47.33-43.69
EBITDA
-147.58-339.05-117.66-122.54-90.89-67.58
D&A For EBITDA
0.132.893.533.492.531.43
EBIT
-147.71-341.94-121.19-126.04-93.42-69.02
SEC Filings: 10-K · 10-Q